Zobrazeno 1 - 10
of 1 540
pro vyhledávání: '"Galicia-Garcia U"'
Autor:
González-Recio I; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain., Goikoetxea-Usandizaga N; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain., Rejano-Gordillo CM; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Sciences, University of Extremadura, University Institute of Biosanitary Research of Extremadura (INUBE), 06071 Badajoz, Spain.; Biofisika Institute, Consejo Superior de Investigaciones Científicas (CSIC), Departamento Bioquímica y Biología Molecular, Facultad de Ciencia y Tecnología, Universidad del País Vasco (UPV/EHU), Leioa, Spain., Conter C; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain., Rodríguez Agudo R; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain., Serrano-Maciá M; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain., Zapata-Pavas LE; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain., Peña-Sanfélix P; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain., Azkargorta M; Proteomics Platform, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain., Elortza F; Proteomics Platform, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain., Herranz JM; Hepatology Programme, CIMA, Idisna, Universidad de Navarra, Avda, Pio XII, n 55, 31008 Pamplona, Spain., Guillamon Thiery Á; Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS, Barcelona, Catalonia, Spain., Guerra-Ruiz AR; Clinical Biochemistry Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Jover R; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain.; Experimental Hepatology Joint Research Unit, IIS Hospital La Fe & Dep. Biochemistry, University of Valencia, Spain., Galicia-Garcia U; Biofisika Institute, Consejo Superior de Investigaciones Científicas (CSIC), Departamento Bioquímica y Biología Molecular, Facultad de Ciencia y Tecnología, Universidad del País Vasco (UPV/EHU), Leioa, Spain., Martín C; Biofisika Institute, Consejo Superior de Investigaciones Científicas (CSIC), Departamento Bioquímica y Biología Molecular, Facultad de Ciencia y Tecnología, Universidad del País Vasco (UPV/EHU), Leioa, Spain., Schaeper U; Silence Therapeutics GmbH, Berlin, Robert Rössle Strasse 10, 13125, Berlin, Germany., Delgado TC; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain., Díaz-Moreno I; Institute for Chemical Research (IIQ), Scientific Research Centre 'Isla de la Cartuja' (cicCartuja), University of Seville - CSIC, Avda. Américo Vespucio 49, 41092 Seville, Spain., Díaz Quintana A; Departamento de Bioquímica Vegetal y Biologia Molecular, Facultad de Biología, Universidad de Sevilla, C. San Fernando 4, 41004 Sevilla (Spain)., Buccella D; Department of Chemistry, New York University, New York, New York 10003, United States., Nogueiras R; Molecular Metabolism Lab, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Av. Barcelona, Campus Vida, Santiago de Compostela University, 15782 Santiago de Compostela, Spain., Argemi J; Hepatology Program, Centro de Investigación Médica Aplicada (CIMA), Liver Unit, Clinica Universidad de Navarra (CUN), Instituto de Investigación de Navarra (IdisNA), University of Navarra, Pamplona, Spain.; Center for Liver Diseases, Pittsburgh Liver Research Center, Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA., Ávila MA; Hepatology Programme, CIMA, Idisna, Universidad de Navarra, Avda, Pio XII, n 55, 31008 Pamplona, Spain., Gratacós-Ginès J; Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS, Barcelona, Catalonia, Spain., Iruzubieta P; Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital, Clinical and Translational Digestive Research Group, IDIVAL, Santander, Spain., Pose E; Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS, Barcelona, Catalonia, Spain., Bataller R; Center for Liver Diseases, Pittsburgh Liver Research Center, Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA., Crespo J; Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital, Clinical and Translational Digestive Research Group, IDIVAL, Santander, Spain., Martínez-Cruz LA; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain., Martínez-Chantar ML; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
Publikováno v:
Hepatology (Baltimore, Md.) [Hepatology] 2024 Dec 06. Date of Electronic Publication: 2024 Dec 06.
Autor:
Larrea-Sebal A; Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., Leioa, Bizkaia, 48940, Spain.; Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, Leioa, Bizkaia, 48940, Spain.; Fundación Biofisika Bizkaia, Barrio Sarriena s/n., Leioa, Bizkaia, 48940, Spain., Sasiain I; Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, Leioa, Bizkaia, 48940, Spain., Jebari-Benslaiman S; Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., Leioa, Bizkaia, 48940, Spain.; Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, Leioa, Bizkaia, 48940, Spain., Galicia-Garcia U; Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., Leioa, Bizkaia, 48940, Spain.; Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, Leioa, Bizkaia, 48940, Spain., Uribe KB; Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, Leioa, Bizkaia, 48940, Spain., Benito-Vicente A; Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., Leioa, Bizkaia, 48940, Spain.; Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, Leioa, Bizkaia, 48940, Spain., Gracia-Rubio I; Lipid Unit, Hospital Universitario Miguel Servet, IIS Aragon, CIBERCV, Universidad de Zaragoza, Zaragoza, 50009, Spain., Bediaga-Bañeres H; Department of Physical Chemistry, University of Basque Country UPV/EHU, Leioa, 48940, Spain., Arrasate S; Department of Organic and Chemistry, University of the Basque Country UPV/EHU, Leioa, 48940, Spain., Cenarro A; Lipid Unit, Hospital Universitario Miguel Servet, IIS Aragon, CIBERCV, Universidad de Zaragoza, Zaragoza, 50009, Spain., Civeira F; Lipid Unit, Hospital Universitario Miguel Servet, IIS Aragon, CIBERCV, Universidad de Zaragoza, Zaragoza, 50009, Spain., González-Díaz H; Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., Leioa, Bizkaia, 48940, Spain.; Ikerbasque, Basque Foundation for Science, Bilbao, Bizkaia, 48013, Spain., Martín C; Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., Leioa, Bizkaia, 48940, Spain.; Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, Leioa, Bizkaia, 48940, Spain.
Publikováno v:
Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Apr; Vol. 11 (13), pp. e2305177. Date of Electronic Publication: 2024 Jan 23.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Larrea-Sebal A; Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, 48080, Bilbao, Spain.; Department of Molecular Biophysics, Biofisika Institute, University of Basque Country and Consejo Superior de Investigaciones Científicas (UPV/EHU, CSIC), 48940, Leioa, Spain.; Fundación Biofisika Bizkaia, 48940, Leioa, Spain., Jebari-Benslaiman S; Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, 48080, Bilbao, Spain.; Department of Molecular Biophysics, Biofisika Institute, University of Basque Country and Consejo Superior de Investigaciones Científicas (UPV/EHU, CSIC), 48940, Leioa, Spain., Galicia-Garcia U; Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, 48080, Bilbao, Spain.; Department of Molecular Biophysics, Biofisika Institute, University of Basque Country and Consejo Superior de Investigaciones Científicas (UPV/EHU, CSIC), 48940, Leioa, Spain., Jose-Urteaga AS; Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, 48080, Bilbao, Spain., Uribe KB; Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, 48080, Bilbao, Spain., Benito-Vicente A; Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, 48080, Bilbao, Spain.; Department of Molecular Biophysics, Biofisika Institute, University of Basque Country and Consejo Superior de Investigaciones Científicas (UPV/EHU, CSIC), 48940, Leioa, Spain., Martín C; Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, 48080, Bilbao, Spain. cesar.martin@ehu.eus.; Department of Molecular Biophysics, Biofisika Institute, University of Basque Country and Consejo Superior de Investigaciones Científicas (UPV/EHU, CSIC), 48940, Leioa, Spain. cesar.martin@ehu.eus.
Publikováno v:
Current atherosclerosis reports [Curr Atheroscler Rep] 2023 Nov; Vol. 25 (11), pp. 839-859. Date of Electronic Publication: 2023 Oct 17.
Autor:
Palma, D., Cardiero, G., Flagiello, C., Galicia-Garcia, U., Larrea, A., Di Taranto, M.D., Martin, C., Iannuzzo, G., Di Minno, M.N.D., Pipolo, A., Fortunato, G.
Publikováno v:
In Atherosclerosis August 2022 355
Silencing of PCSK9 by SIRNA-functionalized RHDL as tool to upregulate LDLR expression in hepatocytes
Autor:
Larrea, A., Benslaiman, S. Jebari, Galicia-Garcia, U., Uribe, K.B., Benito-Vicente, A., Martin, C.
Publikováno v:
In Atherosclerosis August 2022 355
Autor:
Benslaiman, S. Jebari, Uribe, K.B., Benito-Vicente, A., Galicia-Garcia, U., Larrea, A., Alloza, I., Vandenbroeck, K., Martín, C.
Publikováno v:
In Atherosclerosis August 2022 355
Autor:
Larrea-Sebal, A., Benito-Vicente, A., Fernandez-Higuero, J.A., Jebari-Benslaiman, S., Galicia-Garcia, U., Uribe, K.B., Cenarro, A., Ostolaza, H., Civeira, F., Arrasate, S., González-Díaz, H., Martín, C.
Publikováno v:
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
instname
Untreated familial hypercholesterolemia (FH) leads to atherosclerosis and early cardiovascular disease. Mutations in the low-density lipoprotein receptor (LDLr) gene constitute the major cause of FH, and the high number of mutations already described
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::938db6c0fcc9b6a2969af7a8865bdab6
http://hdl.handle.net/10261/311418
http://hdl.handle.net/10261/311418
Autor:
Bea AM; Hospital Universitario Miguel Servet, IIS Aragón, CIBERCV, Spain (A.M.B., V.M.-B., I.L.-M., M.L., P.F.-C., F.C., A.C.)., Larrea-Sebal A; Biofisika Institute (UPV/EHU, CSIC), University of the Basque Country, Leioa, Spain (A.L.-S., C.M.).; Fundación Biofísica Bizkaia, Leioa, Spain (A.L.-S.)., Marco-Benedi V; Hospital Universitario Miguel Servet, IIS Aragón, CIBERCV, Spain (A.M.B., V.M.-B., I.L.-M., M.L., P.F.-C., F.C., A.C.).; Universidad de Zaragoza, Spain (V.M.-B., I.L.-M., M.L., B.M.-F., S.O., F.C.)., Uribe KB; Department of Biochemistry and Molecular Biology, UPV/EHU, University of the Basque Country, Bilbao, Spain (K.B.U., U.G.-G., C.M.).; Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, Spain (K.B.U.)., Galicia-Garcia U; Department of Biochemistry and Molecular Biology, UPV/EHU, University of the Basque Country, Bilbao, Spain (K.B.U., U.G.-G., C.M.)., Lamiquiz-Moneo I; Hospital Universitario Miguel Servet, IIS Aragón, CIBERCV, Spain (A.M.B., V.M.-B., I.L.-M., M.L., P.F.-C., F.C., A.C.).; Universidad de Zaragoza, Spain (V.M.-B., I.L.-M., M.L., B.M.-F., S.O., F.C.)., Laclaustra M; Hospital Universitario Miguel Servet, IIS Aragón, CIBERCV, Spain (A.M.B., V.M.-B., I.L.-M., M.L., P.F.-C., F.C., A.C.).; Universidad de Zaragoza, Spain (V.M.-B., I.L.-M., M.L., B.M.-F., S.O., F.C.)., Moreno-Franco B; Universidad de Zaragoza, Spain (V.M.-B., I.L.-M., M.L., B.M.-F., S.O., F.C.)., Fernandez-Corredoira P; Hospital Universitario Miguel Servet, IIS Aragón, CIBERCV, Spain (A.M.B., V.M.-B., I.L.-M., M.L., P.F.-C., F.C., A.C.)., Olmos S; Universidad de Zaragoza, Spain (V.M.-B., I.L.-M., M.L., B.M.-F., S.O., F.C.).; Aragon Institute of Engineering Research (I3A), Universidad de Zaragoza, Spain (S.O.)., Civeira F; Hospital Universitario Miguel Servet, IIS Aragón, CIBERCV, Spain (A.M.B., V.M.-B., I.L.-M., M.L., P.F.-C., F.C., A.C.).; Universidad de Zaragoza, Spain (V.M.-B., I.L.-M., M.L., B.M.-F., S.O., F.C.)., Martin C; Hospital Universitario Miguel Servet, IIS Aragón, CIBERCV, Spain (A.M.B., V.M.-B., I.L.-M., M.L., P.F.-C., F.C., A.C.).; Department of Biochemistry and Molecular Biology, UPV/EHU, University of the Basque Country, Bilbao, Spain (K.B.U., U.G.-G., C.M.)., Cenarro A; Hospital Universitario Miguel Servet, IIS Aragón, CIBERCV, Spain (A.M.B., V.M.-B., I.L.-M., M.L., P.F.-C., F.C., A.C.).; Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain (A.C.).
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2023 Jun; Vol. 43 (6), pp. 1066-1077. Date of Electronic Publication: 2023 Apr 13.
Autor:
Benito-Vicente A; Biofisika Institute (UPV/EHU, CSIC), University of the Basque Country, Leioa, Spain (A.B.-V., A.L.-S., U.G.-G., S.J.-B., C.M.).; Department of Biochemistry and Molecular Biology, UPV/EHU, University of the Basque Country, Bilbao, Spain (A.B.-V., S.J.-B., C.M.)., Uribe KB; Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, Spain (K.B.U.)., Larrea-Sebal A; Biofisika Institute (UPV/EHU, CSIC), University of the Basque Country, Leioa, Spain (A.B.-V., A.L.-S., U.G.-G., S.J.-B., C.M.).; Fundación Biofísica Bizkaia, Leioa, Spain (A.L.-S., U.G.-G.)., Palacios L; Progenika Biopharma, a Grifols Company, Derio, Spain (L.P., M.S.)., Cenarro A; Lipid Unit, Hospital Universitario Miguel Servet, IIS Aragon, CIBERCV, Universidad de Zaragoza, Spain (A.C., F.C.)., Calle X; Institute of Biological Phychiatry, Mental Health Services, University Hospital, Copenhagen, Denmark (X.C.)., Galicia-Garcia U; Biofisika Institute (UPV/EHU, CSIC), University of the Basque Country, Leioa, Spain (A.B.-V., A.L.-S., U.G.-G., S.J.-B., C.M.).; Fundación Biofísica Bizkaia, Leioa, Spain (A.L.-S., U.G.-G.)., Jebari-Benslaiman S; Biofisika Institute (UPV/EHU, CSIC), University of the Basque Country, Leioa, Spain (A.B.-V., A.L.-S., U.G.-G., S.J.-B., C.M.).; Department of Biochemistry and Molecular Biology, UPV/EHU, University of the Basque Country, Bilbao, Spain (A.B.-V., S.J.-B., C.M.)., Sánchez-Hernández RM; Endocrinology Department, Complejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria and Instituto Universitario de Investigación Biomédica y Sanitaria (IUIBS) de la Universidad de Las Palmas de Gran Canaria, Spain (R.M.S.-H.)., Stef M; Progenika Biopharma, a Grifols Company, Derio, Spain (L.P., M.S.)., Lambert G; Inserm, Laboratoire UMR1188 DéTROI, Sainte Clotilde, France (G.L.).; Université de La Réunion, Faculté de Médecine, Saint Denis de La Réunion, France (G.L.)., Civeira F; Lipid Unit, Hospital Universitario Miguel Servet, IIS Aragon, CIBERCV, Universidad de Zaragoza, Spain (A.C., F.C.)., Martín C; Biofisika Institute (UPV/EHU, CSIC), University of the Basque Country, Leioa, Spain (A.B.-V., A.L.-S., U.G.-G., S.J.-B., C.M.).; Department of Biochemistry and Molecular Biology, UPV/EHU, University of the Basque Country, Bilbao, Spain (A.B.-V., S.J.-B., C.M.).
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2022 Jul; Vol. 42 (7), pp. e203-e216. Date of Electronic Publication: 2022 May 05.